Syntone Ventures LLC

Syntone Ventures LLC is listed in filings as 10% Owner at Outlook Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 17, 2024, including purchase activity. Recent filings connect the profile to Outlook Therapeutics, Inc. (OTLK). The current snapshot covers public activity from Apr 17, 2024. Reported amounts are shown as $8.3M to $5.0M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.